Looking at the cross-sectional studies assessing age effects upon cortical thickness asymmetry, results have been inconsistent. The study authors investigated whether and where cerebral hemispheres thin at different rates.
Despite the many loci associated with late-onset Alzheimer disease, researchers are still short of a robust, unified method of risk stratification based on genome variations due to the clinical heterogeneity and polygenic nature of the disease.
This study looks at how the lack of awareness (anosognosia) of memory impairment evolves in the trajectory of Alzheimer disease.
At AAIC 2020, 2 presentations separately discussed observing a reduced risk of AD in patients who received the influenza and pneumonia vaccines.
Antiepileptic drugs are associated with a higher risk for mortality in patients with Alzheimer disease.
Tauvid is indicated for use with positron emission tomography (PET) imaging of the brain.
High body weight variability may be associated with increased risk for all-cause dementia and Alzheimer dementia in older patients.
A subset of patients at risk for Alzheimer disease because of systemic inflammation may benefit from receiving a tumor necrosis factor (TNF) blocking agent.
Researchers explored the association between midlife serum uric acid and the risk for cognitive decline and dementia.
Limited tools are available for identifying, diagnosing, and treating cognitive dysfunction from Alzheimer disease.
